D-1045-2016 Class III Terminated
FDA drug recall D-1045-2016 was initiated by Sandoz, Inc on May 2, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing. The recall status is terminated (terminated Aug 17, 2017). Affected quantity: 78,606 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 29, 2016
- Initiation Date
- May 2, 2016
- Termination Date
- Aug 17, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 78,606 bottles
Product description
Dicloxacillin Sodium Capsules, USP 250mg, Rx Only, 100 Capsule Bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc., Princeton, NJ 08540, Product of Spain, NDC 0781-2248-01
Reason for recall
Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.
Distribution pattern
Nationwide
Code information
Lot #s: EN3846, Exp 08/2016; FA4809, Exp 2/2017, FW3654 , Exp11/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1045-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026